Advances in the Management of Pancreatic Adenocarcinoma
The approval of therapies indicated for patients with rare mutations and the recommendation for testing all patients with pancreatic cancer has changed the testing and treatment landscape significantly. Health care professionals (HCP) need to be well versed in the potential for actionable mutations and how to counsel patients accordingly.
  • Pancreatic Cancer
  • Recorded Webcast
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation